Search

Your search keyword '"Fuller, Deborah H."' showing total 229 results

Search Constraints

Start Over You searched for: Author "Fuller, Deborah H." Remove constraint Author: "Fuller, Deborah H."
229 results on '"Fuller, Deborah H."'

Search Results

1. De novo design of miniprotein antagonists of cytokine storm inducers

2. Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals

3. Anti-PD-1 chimeric antigen receptor T cells efficiently target SIV-infected [CD4.sup.+] T cells in germinal centers

4. Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

5. Massively parallel de novo protein design for targeted therapeutics

6. Effects of persistent modulation of intestinal microbiota on SIV/HIV vaccination in rhesus macaques

8. Evaluation of the immunogenicity and efficacy of an rVSV vaccine against Zika virus infection in macaca nemestrina

12. Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice

14. Detailed analysis of antibody responses to SARS-CoV-2 vaccination and infection in macaques

15. In Vivo Hematopoietic Stem Cell Gene Therapy for SARS-CoV2 Infection Using a Decoy Receptor

16. Impact of progesterone on innate immunity and cell death after influenza A virus H1N1 2009 infection of lung and placental cells in vitro

17. A Single Dose SARS-CoV-2 Replicon RNA Vaccine Induces Cellular and Humoral Immune Responses in Simian Immunodeficiency Virus Infected and Uninfected Pigtail Macaques

18. Macaque-human differences in SARS-CoV-2 Spike antibody response elicited by vaccination or infection

22. Rapid progression is associated with lymphoid follicle dysfunction in SIV-infected infant rhesus macaques

23. Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

24. Engagement of monocytes, NK cells, and CD4(+) Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition

25. Recrudescence of Natural Coccidioidomycosis During Combination Antiretroviral Therapy in a Pigtail Macaque Experimentally Infected with Simian Immunodeficiency Virus

26. Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV Challenge

27. De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2

30. Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2

31. An HIV Vaccine Targeting the V2 Region of the HIV Envelope Induces a Highly Durable Polyfunctional Fc-Mediated Antibody Response in Rhesus Macaques

33. Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth Development

34. Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition

36. A Single Dose SARS-CoV-2 Replicon RNA Vaccine Induces Cellular and Humoral Immune Responses in Simian Immunodeficiency Virus Infected and Uninfected Pigtail Macaques.

37. Transient Immune Activation in BCG-Vaccinated Infant Rhesus Macaques Is Not Sufficient to Influence Oral Simian Immunodeficiency Virus Infection

38. Simian-Human Immunodeficiency Virus SHIV.CH505 Infection of Rhesus Macaques Results in Persistent Viral Replication and Induces Intestinal Immunopathology

39. Multimeric Epitope-Scaffold HIV Vaccines Target V1V2 and Differentially Tune Polyfunctional Antibody Responses

40. Mucosal T Helper 17 and T Regulatory Cell Homeostasis Correlate with Acute Simian Immunodeficiency Virus Viremia and Responsiveness to Antiretroviral Therapy in Macaques

41. Letter to the Editor: Prior Infection with Coccidioidomycosis in Nonhuman Primates and Impact on Simian Immunodeficiency Virus Disease and Vaccine Immunogenicity.

42. Transient Immune Activation in BCG-Vaccinated Infant Rhesus Macaques Is Not Sufficient to Influence Oral Simian Immunodeficiency Virus Infection.

43. Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition.

44. Multimeric Epitope-Scaffold HIV Vaccines Target V1V2 and Differentially Tune Polyfunctional Antibody Responses

45. Computational design of trimeric influenza-neutralizing proteins targeting the hemagglutinin receptor binding site

47. Minor Antigen Vaccine-Sensitized DLI

49. Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens

Catalog

Books, media, physical & digital resources